Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
Euri Seo, Jeong Jin Yu, Hyun Ok Jun, Eun Jung Shin, Jae Suk Baek, Young-Hwue Kim, Jae-Kon Ko
Korean J Pediatr. 2016;59(10):408-413.   Published online 2016 Oct 17     DOI: https://doi.org/10.3345/kjp.2016.59.10.408
Citations to this article as recorded by Crossref logo
A new model for predicting intravenous immunoglobin-resistant Kawasaki disease in Chongqing: a retrospective study on 5277 patients
Xu-Hai Tan, Xiao-Wei Zhang, Xiao-Yun Wang, Xiang-Qian He, Chu Fan, Tie-Wei Lyu, Jie Tian
Scientific Reports.2019;[Epub]     CrossRef
Dermatology and Immunoglobulin Therapy: Who to Treat and How to Administer Immunoglobulins
F.J. Navarro-Triviño, I. Pérez-López, R. Ruíz-Villaverde
Actas Dermo-Sifiliográficas (English Edition).2018; 109(4): 323.     CrossRef
Dermatología e inmunoglobulinas. ¿A quién y cómo administrarlas?
F.J. Navarro-Triviño, I. Pérez-López, R. Ruíz-Villaverde
Actas Dermo-Sifiliográficas.2018; 109(4): 323.     CrossRef
Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment
Yu-Mi Seo, Hyun-Mi Kang, Sung-Churl Lee, Jae-Won Yu, Hong-Ryang Kil, Jung-Woo Rhim, Ji-Whan Han, Kyung-Yil Lee
Korean Journal of Pediatrics.2018; 61(5): 160.     CrossRef